Medicalsystem Biotechnology Co., Ltd (SHE:300439)

China · Delayed Price · Currency is CNY

8.29

+0.28 (3.50%)

Jun 29, 2026, 3:04 PM CST

-20.59% (1Y)

Market Cap	3.08B -22.2%
Revenue (ttm)	1.54B -5.7%
Net Income	66.57M -68.2%
EPS	0.17 -68.8%
Shares Out	384.32M
PE Ratio	47.39
Forward PE	n/a
Dividend	0.03 (0.41%)
Ex-Dividend Date	Jun 11, 2026

Volume	4,247,500
Open	8.03
Previous Close	8.01
Day's Range	7.83 - 8.31
52-Week Range	7.98 - 12.20
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHE:300439

Medicalsystem Biotechnology Co., Ltd. engages in the research, development, production, and sales of in vitro diagnostic products in China. It is also involved in the provision of Three-party medical diagnosis services. The company offers automated chemistry analyzers; and automated chemiluminescence immunoassay analyzer; hematology analyzers and reagents; total laboratory automation system; mass spectrometry; and, blood lipid subfraction analyzer, and POCT.It also provides healthcare services. Medicalsystem Biotechnology Co., Ltd. was formerly... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 2003

Employees 1,936

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300439

Full Company Profile

Financial Performance

In 2025, SHE:300439's revenue was 1.54 billion, a decrease of -11.67% compared to the previous year's 1.74 billion. Earnings were 63.20 million, a decrease of -75.50%.

Financial Statements